Indian Society15 October 20264 min read
India's TB incidence falls 21% in 2015-2024 against 12% global decline, WHO report says
India's tuberculosis (TB) incidence fell 21% between 2015 and 2024, compared with a global decline of 12%, according to the World Health Organization's Global Tuberculosis Report 2025. Treatment coverage in India has risen to 92%, but the country still accounts for 25% of global TB cases.
The government has intensified the TB Mukt Bharat Abhiyaan, expanded screening and preventive treatment, and launched JOSH (Joint Squad for Health) teams to strengthen community participation.
The programme behind the numbers
In 2020, the Revised National Tuberculosis Control Programme was renamed the National Tuberculosis Elimination Programme (NTEP). The new name reflected India's goal of eliminating TB by 2025, five years ahead of the 2030 global target under Sustainable Development Goal 3 (SDG 3).
The NTEP follows the four pillars of the National Strategic Plan: Detect, Treat, Prevent and Build. It also covers engagement with private healthcare providers, contact tracing, and a multisectoral approach to the social determinants of TB, including malnutrition, poverty and inadequate living conditions.
Campaigns and patient support
The Pradhan Mantri TB Mukt Bharat Abhiyaan began on 9 September 2022 as an additional component of the NTEP. It seeks to make TB elimination a Jan Andolan, or people's movement, involving community organisations, civil society and corporate entities through Corporate Social Responsibility (CSR).
The Ni-kshay Poshan Yojana, launched in 2018, gives each notified TB patient ₹1,000 a month by Direct Benefit Transfer. Since April 2018, about ₹4,454.68 crore has been paid into the bank accounts of 1.38 crore beneficiaries.
Under the Ni-kshay Mitra initiative, individuals, NGOs, corporations and community groups provide food baskets, psychosocial assistance and vocational support to patients. More than 2 lakh MY Bharat volunteers have signed up as Ni-kshay Mitras.
The Ministry of Health and Family Welfare launched the 100-Day TB Mukt Bharat Abhiyaan on 7 December 2024 in 347 high-priority districts across 33 States and Union Territories. It involved more than 30,000 elected representatives and 24 line ministries, and its strategies were later expanded nationwide. As of June 2026, over 28.1 crore people had been screened, more than 20 lakh had received TB preventive treatment, and 5.7 lakh new Ni-kshay Mitras had joined. The campaign reported a treatment success rate of 90%, against a global average of 88%.
A second phase from March 2026 organised more than 1.7 lakh Ayushman Arogya Shivirs across 1.2 lakh high-risk villages and wards, with 32 lakh students and 1.9 lakh MY Bharat volunteers taking part.
Treatment and technology
The BPaLM regimen, a combination of Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, offers a shorter six-month option for eligible patients with multidrug-resistant or rifampicin-resistant TB. More than 15,000 patients have been started on it. TB preventive treatment is offered to household contacts of patients, people living with HIV and other vulnerable groups.
Diagnostic capacity includes more than 9,800 rapid molecular testing facilities and 107 culture and drug susceptibility testing laboratories. More than 500 AI-enabled handheld chest X-ray units are in use for community screening, with another 1,500 being delivered to States and Union Territories. The government says the handheld units have contributed to a 34-fold increase in X-ray screening.
The Ni-kshay platform supports case management, patient monitoring and delivery of nutritional assistance. The AI-powered Khushi chatbot gives information on TB symptoms and helps users find nearby diagnostic centres.
Other AI tools include:
- Cough Against TB, which analyses a three-second cough recording on a smartphone; more than 1.62 lakh people have been screened, with a reported 12-16% additional case yield over conventional methods.
- Adverse outcome prediction, which flags patients at higher risk of treatment failure and has reported a 27% decline in adverse outcomes after nationwide deployment.
- DeepCXR, which reads digital chest X-rays for abnormalities such as nodules and cavities, deployed in eight States and Union Territories and provided to the government free of cost to address specialist shortages.
Ayushman Arogya Mandirs, primary healthcare facilities under the Ayushman Bharat framework, provide TB screening and referral. As of 13 October 2026, India had 1,87,250 of them.
Community mobilisation through JOSH
Each JOSH team comprises MY Bharat volunteers, National Cadet Corps cadets and a designated Class-I officer. The teams are meant to promote TB awareness, early screening, timely treatment and adherence, and to reduce stigma. The Ministry of Health and Family Welfare has piloted them in 11 States and 55 districts, alongside a nationwide social media campaign.
The government says early diagnosis, preventive treatment, access to quality healthcare and patient support remain its priorities, with India still accounting for a quarter of the world's cases.